|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q79862472
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000154.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q79862472
|
|
024
|
|
|
‡a
0000-0001-7205-2510
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q79862472
|
|
100
|
0 |
|
‡a
Sandro Gomes Soares
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
S G Soares
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Cloning, expression and purification of a glycosylated form of the DNA-binding protein Dps from Salmonella enterica Typhimurium.
|
|
670
|
|
|
‡a
Author's Comparative analysis of the pathological events involved in immune and non-immune TRALI models.
|
|
670
|
|
|
‡a
Author's Expression of complement system regulatory molecules in the endometrium of normal ovulatory and hyperstimulated women correlate with menstrual cycle phase
|
|
670
|
|
|
‡a
Author's Expression of recombinant human antibody fragments capable of inhibiting the phospholipase and myotoxic activities of Bothrops jararacussu venom.
|
|
670
|
|
|
‡a
Author's Macrophages from chickens selected for high antibody response produced more nitric oxide and have greater phagocytic capacity.
|
|
670
|
|
|
‡a
Author's Nasal vaccination with attenuated Salmonella expressing VapA: TLR2 activation is not essential for protection against R. equi infection.
|
|
670
|
|
|
‡a
Author's Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157:H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice.
|
|
670
|
|
|
‡a
Author's Structure and dynamics of Toll immunoreceptor activation in the mosquito Aedes aegypti
|
|
670
|
|
|
‡a
Author's The recognition of N-glycans by the lectin ArtinM mediates cell death of a human myeloid leukemia cell line
|
|
670
|
|
|
‡a
Author's Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection.
|
|
670
|
|
|
‡a
Author's Vaccination of Mice with Virulence-Associated Protein G (VapG) Antigen Confers Partial Protection against Rhodococcus equi Infection through Induced Humoral Immunity
|
|
670
|
|
|
‡a
Author's Venom-sweet-venom: N-linked glycosylation in snake venom toxins.
|
|
670
|
|
|
‡a
Author's Yeast expressed ArtinM shares structure, carbohydrate recognition, and biological effects with native ArtinM
|
|
909
|
|
|
‡a
(orcid) 0000000172052510
‡9
1
|
|
919
|
|
|
‡a
expressionofrecombinanthumanantibodyfragmentscapableofinhibitingthephospholipaseandmyotoxicactivitiesofbothropsjararacussuvenom
‡A
Expression of recombinant human antibody fragments capable of inhibiting the phospholipase and myotoxic activities of Bothrops jararacussu venom.
‡9
1
|
|
919
|
|
|
‡a
recognitionofnglycansbythelectinartinmmediatescelldeathofahumanmyeloidleukemiacellline
‡A
The recognition of N-glycans by the lectin ArtinM mediates cell death of a human myeloid leukemia cell line
‡9
1
|
|
919
|
|
|
‡a
comparativeanalysisofthepathologicaleventsinvolvedinimmuneandnonimmunetralimodels
‡A
Comparative analysis of the pathological events involved in immune and non-immune TRALI models.
‡9
1
|
|
919
|
|
|
‡a
vaccinationofmicewithsalmonellaexpressingvapamucosalandsystemicth1responsesprovideprotectionagainstrhodococcusequiinfection
‡A
Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection.
‡9
1
|
|
919
|
|
|
‡a
cloningexpressionandpurificationofaglycosylatedformofthednabindingproteindpsfromsalmonellaentericatyphimurium
‡A
Cloning, expression and purification of a glycosylated form of the DNA-binding protein Dps from Salmonella enterica Typhimurium.
‡9
1
|
|
919
|
|
|
‡a
vaccinationofmicewithvirulenceassociatedproteingvapgantigenconferspartialprotectionagainstrhodococcusequiinfectionthroughinducedhumoralimmunity
‡A
Vaccination of Mice with Virulence-Associated Protein G (VapG) Antigen Confers Partial Protection against Rhodococcus equi Infection through Induced Humoral Immunity
‡9
1
|
|
919
|
|
|
‡a
venomsweetvenomnlinkedglycosylationinsnakevenomtoxins
‡A
Venom-sweet-venom: N-linked glycosylation in snake venom toxins.
‡9
1
|
|
919
|
|
|
‡a
yeastexpressedartinmsharesstructurecarbohydraterecognitionandbiologicaleffectswithnativeartinm
‡A
Yeast expressed ArtinM shares structure, carbohydrate recognition, and biological effects with native ArtinM
‡9
1
|
|
919
|
|
|
‡a
structureanddynamicsoftollimmunoreceptoractivationinthemosquitoaedesaegypti
‡A
Structure and dynamics of Toll immunoreceptor activation in the mosquito Aedes aegypti
‡9
1
|
|
919
|
|
|
‡a
expressionofcomplementsystemregulatorymoleculesintheendometriumofnormalovulatoryandhyperstimulatedwomencorrelatewithmenstrualcyclephase
‡A
Expression of complement system regulatory molecules in the endometrium of normal ovulatory and hyperstimulated women correlate with menstrual cycle phase
‡9
1
|
|
919
|
|
|
‡a
oralimmunizationwithattenuatedsalmonellavaccineexpressingescherichiacolio157h7intimingammatriggersbothsystemicandmucosalhumoralimmunityinmice
‡A
Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157:H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice.
‡9
1
|
|
919
|
|
|
‡a
nasalvaccinationwithattenuatedsalmonellaexpressingvapatlr2activationisnotessentialforprotectionagainstrequiinfection
‡A
Nasal vaccination with attenuated Salmonella expressing VapA: TLR2 activation is not essential for protection against R. equi infection.
‡9
1
|
|
919
|
|
|
‡a
macrophagesfromchickensselectedforhighantibodyresponseproducedmorenitricoxideandhavegreaterphagocyticcapacity
‡A
Macrophages from chickens selected for high antibody response produced more nitric oxide and have greater phagocytic capacity.
‡9
1
|
|
996
|
|
|
‡2
LC|no2019016756
|
|
996
|
|
|
‡2
ISNI|0000000069183379
|
|
996
|
|
|
‡2
ISNI|000000044458452X
|
|
996
|
|
|
‡2
PTBNP|195115
|
|
996
|
|
|
‡2
SUDOC|147206359
|
|
996
|
|
|
‡2
LC|n 2019250974
|
|
996
|
|
|
‡2
DNB|1305092694
|
|
996
|
|
|
‡2
PTBNP|106653
|
|
996
|
|
|
‡2
PTBNP|106652
|
|
996
|
|
|
‡2
BNF|15127302
|
|
996
|
|
|
‡2
PTBNP|1839698
|
|
996
|
|
|
‡2
BLBNB|001604672
|
|
996
|
|
|
‡2
ISNI|0000000496543623
|
|
996
|
|
|
‡2
PTBNP|33041
|
|
996
|
|
|
‡2
ISNI|0000000067246145
|
|
996
|
|
|
‡2
BLBNB|000385042
|
|
996
|
|
|
‡2
PTBNP|1044171
|
|
996
|
|
|
‡2
ISNI|000000006660641X
|
|
996
|
|
|
‡2
LC|n 2007022943
|
|
996
|
|
|
‡2
LC|n 81094141
|
|
996
|
|
|
‡2
LC|n 82014706
|
|
996
|
|
|
‡2
ISNI|0000000069384322
|
|
996
|
|
|
‡2
BLBNB|001487516
|
|
996
|
|
|
‡2
BLBNB|001489988
|
|
996
|
|
|
‡2
SUDOC|24868647X
|
|
996
|
|
|
‡2
SUDOC|237522039
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
